Literature DB >> 18382724

ASCI: reflections on the first 100 years and a proposal for the next.

William N Kelley1.   

Abstract

Congratulations to the ASCI and its membership on the first 100 years. From their first organizational meeting on the Boardwalk in Atlantic City in June 1907, our predecessors recognized the need for an organization for the clinician who had a strong interest in true experimental medicine. These nine Young Turks formed the Society, had their first meeting at the Willard Hotel in Washington, DC, in 1909, and went on to become some of the leaders of American medicine in the first half of the 20th century. The establishment of the JCI in 1924 further enhanced the high standards of the ASCI and its membership. Surely thousands of us have benefited from the foundation of the ASCI and the JCI, as have, I would submit, millions of patients as well.

Entities:  

Mesh:

Year:  2008        PMID: 18382724      PMCID: PMC2276772          DOI: 10.1172/JCI34652

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  3 in total

Review 1.  Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout.

Authors:  W N Kelley; M L Greene; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

2.  Clinical investigation and the clinical investigator: the past, present, and future.

Authors:  W N Kelley
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

3.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

  3 in total
  2 in total

Review 1.  A history of the American Society for Clinical Investigation.

Authors:  Joel D Howell
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

2.  Something lost--something gained: the ASCI begins its second century.

Authors:  Charles L Sawyers
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.